M&T Bank
FDMT icon

M&T Bank’s 4D Molecular Therapeutics FDMT Stock Holding History

M&T Bank’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,487
Closed -$209K – 1594
2024
Q4 		$209K Buy
37,487
+18,639
+99% +$146K ﹤0.01% 1515
2024
Q3 		$204K Sell
18,848
-10,161
-35% -$169K ﹤0.01% 1514
2024
Q2 		$609K Sell
29,009
-334
-1% -$8.38K ﹤0.01% 1039
2024
Q1 		$935K Sell
29,343
-10,168
-26% -$259K ﹤0.01% 906
2023
Q4 		$800K Buy
39,511
+30
+0.1% +$395 ﹤0.01% 952
2023
Q3 		$503K Buy
39,481
+10,667
+37% +$178K ﹤0.01% 1080
2023
Q2 		$520K Hold
28,814
– – ﹤0.01% 1103
2023
Q1 		$496K Buy
28,814
+5,270
+22% +$102K ﹤0.01% 1120
2022
Q4 		$522K Sell
23,544
-34,712
-60% -$536K ﹤0.01% 1086
2022
Q3 		$468K Buy
58,256
+7,148
+14% +$64.7K ﹤0.01% 1115
2022
Q2 		$356K Buy
51,108
+24,236
+90% +$236K ﹤0.01% 1120
2022
Q1 		$406K Buy
26,872
+14,552
+118% +$229K ﹤0.01% 1079
2021
Q4 		$270K Buy
12,320
+672
+6% +$16.5K ﹤0.01% 1296
2021
Q3 		$314K Buy
11,648
+1,153
+11% +$32.9K ﹤0.01% 1214
2021
Q2 		$253K Hold
10,495
– – ﹤0.01% 1344
2021
Q1 		$455K Hold
10,495
– – ﹤0.01% 1044
2020
Q4 		$435K Buy
+10,495
New +$433K ﹤0.01% 1127

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

M&T Bank's FDMT Position: Q1 2025 in Review

M&T Bank sold out of 4D Molecular Therapeutics (FDMT) in Q1 2025, closing a stake of 37,487 shares — an estimated $209K sold.

M&T Bank first reported a position in FDMT in Q4 2020 and held it in 17 quarters. The position peaked at $935K in Q1 2024. 125 funds tracked by Wall St. Rank hold FDMT as of Q1 2025.

  • M&T Bank reported no remaining 4D Molecular Therapeutics position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 37,487 4D Molecular Therapeutics shares in Q1 2025, an estimated $209K.
  • M&T Bank first reported a position in 4D Molecular Therapeutics in Q4 2020 and held it in 17 quarters.
  • M&T Bank's 4D Molecular Therapeutics position peaked at $935K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.